Bibliography
- De Conno F , GroffL, BrunelliCet al.: Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. J. Clin. Oncol.14, 2836–2842(1996).
- Morley J , BridsonJ, NashT, MilesJ, White S, Makin M: Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial. Palliat. Med.17, 576–587(2003).
- Bruera E , PalmerL, BosnjakSet al.: Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.J. Clin. Oncol.22, 185–192(2004).
- Altier N , DionD, BoulangerA, Choiniere M: Management of chronic neuropathic pain with methadone: a review of 13 cases. Clin. J. Pain21, 364–369(2005).
- Moulin D , PalmaD, WatlingC, SchulzV: Methadone in the management of intractable neuropathic noncancer pain.Can. J. Neurol. Sci.32, 340–343(2005).
- Clinical Practice Guidelines: The management of chronic pain in older persons. J. Am. Geriatr. Soc.46(5), 635–651(1998).
- Ripamonti C , BianchiM: The use of methadone for cancer pain.Hematol. Oncol. Clin. North Am.16, 543–555(2002).
- Toombs J , KralL: Methadone treatment for pain states.Am. Fam. Physician71(7), 1353–1358(2005).
- Mercante S , CasuccioA, FulfaroFet al.: Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study.J. Clin. Oncol.19(11), 2898–2904(2001).
- Cruciani R , SekineR, HomelPet al.: Measurement of QTC in patients receiving chronic methadone therapy.J. Pain Symptom Manage.29(4), 385–391(2005).
- Krantz M , KutinskyI, RobertsonA: Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes.Pharmacotherapy23(6), 802–805(2003).
- Krantz M , LewkowiezL, HaysHet al.: Torsades de pointes associated with very-high dose methadone.Ann. Intern. Med.137, 501–504(2002).
- Sticherling C , SchaerB, AmmannPet al.: Methadone-induced torsades de pointes tachycardias.Swiss Med. Wkly135, 282–285(2005).
- Pasero C , PortenoyK, McCaffertyM: Opioid analgesics. In:Pain Clinical Manual (2nd Edition). Bowlus B (Ed.). Mosby, MO, USA, 185–186(1999).
- Weinberg DS , InturrisiCE, ReidenbergBet al.: Sublingual absorption of selected opioid analgesics. Clin. Pharmacol. Ther.44, 335–337(1988).
- Lugo RA , KernSE: Clinical pharmacokinetics of morphine.J. Pain Palliat. Care Pharmacother.16(4), 5–18(2002).
- Kehl K : Treatment of terminal restlessness: a review of the evidence.J. Pain Palliat. Care Pharmacother.18(1), 5–30(2004).
- Lichter I , HuntE: The last 48 hours of life.J. Palliat. Care6(4), 7–15(1990).
- Lotsch J : Opioid metabolites.J. Pain Symptom Manage.29(44), 10–22(2005).
- Smith MT : Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites.Clin. Exp. Pharmacol. Physiol.27, 524–528(2000).
Website
- International Association for the Study of Pain – Media Pack for Global Day Against Pain: Relief of Pain Should be a Human Right. Global Day Against Pain Annual Meeting, Geneva, Switzerland, October 11 (2004) www.iasp-pain.org
- Fast Facts Concept 75: Methadone for the treatment of pain (article online), (2002) www.eperc.mcw.edu/fastFact/ff_75.htm